Our study demonstrated that high KDM1A expression is significantly associated with worse clinicopathological parameters in patients with breast cancer, with high KDM1A expression indicating a higher frequency of lymph node metastasis, higher histological grade, and more lymphatic invasion. Here, KDM1A is linked to breast carcinoma.